Study to be Presented at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference ...
PLEASANTON, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of a retrospective study …